Package 60505-0183-0

{"route": ["ORAL"], "spl_id": "e6a60bd5-3bd4-783c-7fb0-25fee964d387", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "upc": ["0360505018307"], "unii": ["33CM23913M"], "rxcui": ["308979"], "spl_set_id": ["bf0d012f-da14-8ce3-d74f-56172cddebc5"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (60505-0183-0)", "package_ndc": "60505-0183-0", "marketing_start_date": "20020901"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (60505-0183-1)", "package_ndc": "60505-0183-1", "marketing_start_date": "20020901"}], "brand_name": "CARBAMAZEPINE", "product_id": "60505-0183_e6a60bd5-3bd4-783c-7fb0-25fee964d387", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "60505-0183", "generic_name": "CARBAMAZEPINE", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CARBAMAZEPINE", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "200 mg/1"}], "application_number": "ANDA075948", "marketing_category": "ANDA", "marketing_start_date": "20020901", "listing_expiration_date": "20261231"}